IL63880A0 - Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole - Google Patents

Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole

Info

Publication number
IL63880A0
IL63880A0 IL63880A IL6388081A IL63880A0 IL 63880 A0 IL63880 A0 IL 63880A0 IL 63880 A IL63880 A IL 63880A IL 6388081 A IL6388081 A IL 6388081A IL 63880 A0 IL63880 A0 IL 63880A0
Authority
IL
Israel
Prior art keywords
benzothiazole
trifluoromethoxy
amino
medicament containing
medicament
Prior art date
Application number
IL63880A
Other languages
English (en)
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of IL63880A0 publication Critical patent/IL63880A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
IL63880A 1980-10-17 1981-09-18 Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole IL63880A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8022218A FR2492258A1 (fr) 1980-10-17 1980-10-17 Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole

Publications (1)

Publication Number Publication Date
IL63880A0 true IL63880A0 (en) 1981-12-31

Family

ID=9247013

Family Applications (1)

Application Number Title Priority Date Filing Date
IL63880A IL63880A0 (en) 1980-10-17 1981-09-18 Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole

Country Status (16)

Country Link
US (1) US4370338A (de)
EP (1) EP0050551B1 (de)
JP (1) JPS5795910A (de)
AR (1) AR227069A1 (de)
AU (1) AU545437B2 (de)
CA (1) CA1166159A (de)
DE (1) DE3163230D1 (de)
DK (1) DK444281A (de)
FR (1) FR2492258A1 (de)
GR (1) GR75804B (de)
HU (1) HU184893B (de)
IL (1) IL63880A0 (de)
MA (1) MA19364A1 (de)
NO (1) NO813492L (de)
PT (1) PT73828B (de)
ZA (1) ZA817187B (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
FR2619713B1 (fr) * 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
FR2619712B1 (fr) * 1987-08-25 1990-08-31 Rhone Poulenc Sante Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la schizophrenie
EP0375510B1 (de) * 1988-12-15 1992-11-11 Rhone-Poulenc Sante 2-Imino-6-polyfluoralkoxy-benzothiazol-Derivate, Verfahren zu deren Herstellung und Arzneimittel, die sie enthalten
FR2649705B2 (fr) * 1989-07-13 1994-09-23 Rhone Poulenc Sante Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
FR2640622B1 (fr) * 1988-12-15 1991-03-22 Rhone Poulenc Sante Derives de l'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR2640623B1 (fr) * 1988-12-15 1991-03-22 Rhone Poulenc Sante Derives de la benzothiazoline, leurs procedes de preparation et les medicaments les contenant
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation
FR2640624B1 (fr) * 1988-12-15 1994-08-12 Rhone Poulenc Sante Medicaments a base de derives de la benzothiazolamine-2, nouveaux derives et leur preparation
EP0374041B1 (de) * 1988-12-15 1992-06-17 Rhone-Poulenc Sante 2-Benzothiazolamin-Derivate enthaltende Arzneimittel, Verbindungen und ihre Herstellung
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR2649703B1 (fr) * 1989-07-13 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 polyfluoroalcoxy-6 benzothiazole, leurs procedes de preparation et les medicaments les contenant
FR2649702B1 (fr) * 1989-07-13 1991-11-22 Rhone Poulenc Sante Derives d'alkylimino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
US5260297A (en) * 1989-07-13 1993-11-09 Rhone Poulenc Rorer, S.A. 2-imino-3-alkylbenzothiazoline derivatives bearing a heterocyclic substituent on the alkyl group, their preparation and medicinal products containing them.
DK0409692T3 (da) * 1989-07-13 1994-04-05 Rhone Poulenc Sante Derivater af 2-imino-3-heterocycloalkylbenzothiazolin, deres fremstilling og lægemidler med indhold deraf
FR2649704B1 (fr) * 1989-07-13 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 ethyl-3 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
FR2661910B1 (fr) * 1990-05-11 1992-08-21 Rhone Poulenc Sante Derives d'imino-2 heterocyclylalkyl-3 benzothiazoline, leur preparation et les medicaments les contenant.
FR2662160B1 (fr) * 1990-05-18 1992-07-24 Rhone Poulenc Sante Derives d'alkylthio-3 propyl-3 benzothiazoline leur preparation et les medicaments les contenant.
FR2662694A1 (fr) * 1990-06-05 1991-12-06 Rhone Poulenc Sante Derives du benzoselenazole, leur preparation et les medicaments les contenant.
FR2662695A1 (fr) * 1990-06-05 1991-12-06 Rhone Poulenc Sante Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant.
FR2663030A1 (fr) * 1990-06-05 1991-12-13 Rhone Poulenc Sante Derives selenies de benzothiazoline leur preparation et les medicaments les contenant.
FR2663029B1 (fr) * 1990-06-07 1992-07-31 Rhone Poulenc Sante Derives de benzothiazole, leur preparation et les medicaments les contenant.
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2700116B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants comme radioprotecteurs.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2726271B1 (fr) * 1994-10-26 1996-12-06 Rhone Poulenc Rorer Sa Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
FR2786101B1 (fr) 1998-11-24 2002-07-05 Aventis Laboratoire Utilisation de la nicergoline dans le traitement de la spasticite
FR2787028B1 (fr) 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
WO2000041728A1 (fr) * 1999-01-12 2000-07-20 Takeda Chemical Industries, Ltd. Compositions pour le traitement de la miction frequente et de l'incontinence d'urine
MXPA03004871A (es) 2000-11-30 2003-08-19 Pfizer Prod Inc Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
WO2002043762A2 (en) * 2000-11-30 2002-06-06 Pfizer Products Inc. Combination of gaba agonists and sorbitol dehydrogenase inhibitors
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
EP1737466A1 (de) * 2004-01-29 2007-01-03 Pfizer Products Inc. KOMBINATION VON Y-AMINOBUTTERSÄURE-MODULATOREN UND 5HT-1b REZEPTOR-ANTAGONISTEN
ES2564187T3 (es) * 2005-04-05 2016-03-18 Yale University Agentes de modulación de glutamato en el tratamiento de trastornos mentales
US9629817B2 (en) 2005-08-25 2017-04-25 Steven Michael Weiss Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP2275095A3 (de) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese durch modulation des Muscarinrezeptors
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080108827A1 (en) * 2006-10-25 2008-05-08 Padi Pratap R Process for preparing riluzole
EP2578216A1 (de) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Verfahren zur Behandlung von Fragilem-X-Syndrom
US20090167322A1 (en) * 2007-12-28 2009-07-02 Erik Edmund Magnuson Systems and method for classifying a substance
AU2009231394B2 (en) * 2008-04-03 2013-09-05 F. Hoffmann-La Roche Ag Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2284161A1 (de) 2009-07-21 2011-02-16 Edmond Pharma S.R.L. Verfahren zur Herstellung von Riluzol
WO2016081472A1 (en) * 2014-11-21 2016-05-26 Biohaven Pharmaceutical Holding Company Ltd. Sublingual formulation of riluzole
EA201791110A1 (ru) * 2014-11-21 2017-11-30 Биохэвен Фармасьютикэл Холдинг Компани Лтд. Сублингвальное введение рилузола
AU2016328150B2 (en) 2015-09-23 2020-10-01 Xw Laboratories Inc. Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
TWI788307B (zh) 2016-10-31 2023-01-01 美商艾歐凡斯生物治療公司 用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
WO2018129336A1 (en) 2017-01-06 2018-07-12 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof
KR102378845B1 (ko) 2017-03-30 2022-03-24 엑스더블유파마 리미티드 이환형 헤테로아릴 유도체 및 이의 제조 및 용도
EP3856719B1 (de) 2018-09-30 2023-06-07 XWPharma Ltd. Verbindungen als neuronale histaminrezeptor-3-antagonisten und deren verwendungen
TW202136194A (zh) 2019-12-20 2021-10-01 香港商凱瑞康寧有限公司 ４－纈胺醯氧基丁酸的合成方法
CA3182394A1 (en) 2020-06-18 2021-12-23 Sami Karaborni Controlled release granulations of water-soluble active pharmaceutical ingredients
US11357734B2 (en) 2020-06-18 2022-06-14 XWPharma Ltd. Pharmaceutical granulations of water-soluble active pharmaceutical ingredients
CN116261451A (zh) 2020-07-24 2023-06-13 凯瑞康宁生物工程有限公司 γ-羟基丁酸衍生物的药物组合物和药物动力学
KR20230058151A (ko) 2020-10-05 2023-05-02 엑스더블유파마 리미티드 감마-하이드록시부티르산 유도체의 변형된 방출 조성물
AU2022238423A1 (en) 2021-03-19 2023-10-19 XWPharma Ltd. Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879531A (en) * 1972-07-17 1975-04-22 Uniroyal Inc 2-aminothiazoles compositions and methods for using them as psychotherapeutic agents
US3876653A (en) * 1973-03-26 1975-04-08 Kyowa Hakko Kogyo Kk Benzothiazole derivatives

Also Published As

Publication number Publication date
NO813492L (no) 1982-04-19
JPS5795910A (en) 1982-06-15
AU7654581A (en) 1982-04-22
PT73828B (fr) 1983-01-17
EP0050551B1 (de) 1984-04-18
CA1166159A (fr) 1984-04-24
FR2492258A1 (fr) 1982-04-23
DK444281A (da) 1982-04-18
DE3163230D1 (en) 1984-05-24
GR75804B (de) 1984-08-02
US4370338A (en) 1983-01-25
EP0050551A1 (de) 1982-04-28
JPH0148884B2 (de) 1989-10-20
PT73828A (fr) 1981-11-01
AR227069A1 (es) 1982-09-15
FR2492258B1 (de) 1982-11-26
AU545437B2 (en) 1985-07-11
HU184893B (en) 1984-10-29
MA19364A1 (fr) 1982-07-01
ZA817187B (en) 1982-09-29

Similar Documents

Publication Publication Date Title
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
GB2083755B (en) Syringe
GB2073026B (en) Cannula
IL64160A0 (en) Powdered medicament
DE3167658D1 (en) Inhaler
JPS5722767A (en) Inhaler
JPS57128622A (en) Nitroglycerin medicine medicine
ZA815398B (en) Self-destructable syringes
EG16613A (en) Dosage units
GB2085603B (en) Medicament reservoir
GB2084662B (en) Syringe
JPS57103639A (en) Non-refilling type syringe
JPS56139420A (en) Drug
JPS5775915A (en) Nasal medicine
JPS56150012A (en) Isotomic solution medicine
ZA818221B (en) Pharmaceutical compounds
PT73017A (en) Medicament container
MTP884B (en) Pharmaceutical preparationes
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
JPS5732230A (en) Instetine-soluble capsule
JPS5760300A (en) Collimator
JPS57106613A (en) Pharmacetical medicine
ZA813632B (en) Ampoule
JPS56128163A (en) Irrigator
PH18681A (en) Methoxsalem dosage forms

Legal Events

Date Code Title Description
RH Patent void